Core Viewpoint - The animal health sector experienced a rise of 0.92% on September 11, with Dayu Biological leading the gains, while the overall market indices also showed significant increases [1]. Group 1: Market Performance - The Shanghai Composite Index closed at 3875.31, up 1.65%, and the Shenzhen Component Index closed at 12979.89, up 3.36% [1]. - Dayu Biological's stock price increased by 3.81% to 11.16, with a trading volume of 140,500 shares and a transaction value of 158 million [1]. Group 2: Individual Stock Performance - Other notable performers included: - Houfeng Holdings, up 2.75% to 4.11, with a trading volume of 326,800 shares and a transaction value of 133 million [1]. - Keqian Biological, up 2.15% to 18.50, with a trading volume of 32,400 shares and a transaction value of 59.27 million [1]. - Yongshun Biological, up 1.69% to 10.80, with a trading volume of 48,100 shares and a transaction value of 52.46 million [1]. Group 3: Capital Flow Analysis - The animal health sector saw a net outflow of 70.71 million from institutional investors, while retail investors contributed a net inflow of 77.65 million [2][3]. - The capital flow for individual stocks showed varied trends, with significant outflows from stocks like Zhongmu Co., which had a net outflow of 11.86 million from institutional investors [3].

Group 1 - The horse racing concept sector increased by 2.40%, ranking second in terms of growth among concept sectors, with five stocks rising, including Xinhua Du reaching the daily limit, and *ST Zhengping, Luoniushan, and Zhongti Industry showing notable increases of 4.60%, 1.92%, and 1.45% respectively [1] - The leading stocks in terms of net inflow of main funds in the horse racing concept sector included Xinhua Du with a net inflow of 1.58 billion yuan, followed by Luoniushan and *ST Zhengping with net inflows of 1912.78 million yuan and 724.64 million yuan respectively [1] - The overall market performance showed that the horse racing concept sector attracted a net inflow of 1.52 billion yuan from main funds today [1] Group 2 - In terms of fund inflow ratios, Xinhua Du, Luoniushan, and *ST Zhengping had the highest net inflow rates of 21.21%, 9.48%, and 3.39% respectively [2] - The horse racing concept sector's fund inflow rankings highlighted Xinhua Du with a daily increase of 10.05% and a turnover rate of 14.14%, while Luoniushan and *ST Zhengping had increases of 1.92% and 4.60% respectively [2]

Market Overview - The animal health sector experienced a decline of 0.5% on September 10, with Yongshun Biological leading the drop [1] - The Shanghai Composite Index closed at 3812.22, up 0.13%, while the Shenzhen Component Index closed at 12557.68, up 0.38% [1] Stock Performance - Notable gainers included: - Qudongli (838275) with a closing price of 11.21, up 2.75% [1] - *ST Lvkang (002868) at 26.42, up 1.62% [1] - Houfeng Holdings (002141) at 4.00, up 0.76% [1] - Major decliners included: - Yongshun Biological (839729) at 10.62, down 3.28% [2] - Shilian Biological (688098) at 11.72, down 1.76% [2] - Huai Sheng Biological (300871) at 22.20, down 1.60% [2] Capital Flow Analysis - The animal health sector saw a net outflow of 81.6 million yuan from institutional investors, while retail investors contributed a net inflow of 53.0 million yuan [2] - The detailed capital flow for key stocks showed: - Repu Biological (300119) had a net inflow of 1.12 million yuan from retail investors [3] - Kexian Biological (688526) saw a net inflow of 14.78 thousand yuan from institutional investors [3] - Hai Li Biological (603718) experienced a significant net outflow of 22.66 million yuan from institutional investors [3]

股票代码：600195股票简称：中牧股份编号：临2025-026 中牧实业股份有限公司关于 行使优先配售权参与认购厦门金达威集团股份有限公司 向不特定对象发行可转换公司债券的结果公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 2025年8月18日，中牧实业股份有限公司（以下简称"公司"）召开第九届董事会2025年第十次临时会 议、第九届监事会2025年第一次临时会议审议通过了《关于公司行使优先配售权参与认购厦门金达威集 团股份有限公司向不特定对象发行可转换公司债券的议案》。具体内容详见2025年8月20日刊登在《上 海证券报》以及上海证券交易所网站（www.sse.com.cn）的《中牧实业股份有限公司关于行使优先配售 权参与认购厦门金达威集团股份有限公司向不特定对象发行可转换公司债券的公告》（编号：临2025- 022）。 2025年9月5日，金达威披露了《向不特定对象发行可转换公司债券上市公告书》，金达威本次发行的可 转换公司债券将于2025年9月8日起在深圳证券交易所上市交易。 公司将严格遵守《证券法》《可转换公司 ...

Group 1 - The company exercised its preferential subscription rights to participate in the subscription of Xiamen Jindawei Group Co., Ltd.'s convertible bonds, with a total subscription amount of 24,140.12 million yuan for 2,414,012 bonds at a price of 100 yuan per bond [1][2] - The company received full allocation of the subscribed amount for the convertible bonds, which will be listed for trading on the Shenzhen Stock Exchange starting September 8, 2025 [1] - The company will comply with relevant laws and regulations, including the Securities Law and the Management Measures for Convertible Bonds, and will not reduce its holdings of Jindawei's stocks and convertible bonds within six months from the issuance date [2]

Core Insights - China Agricultural Development Group Co., Ltd. (China Agri-Development Group) held a collective performance briefing for its three listed subsidiaries to share operational results and enhance investor confidence [1][2] Group 1: Company Overview - China Agri-Development Group was established in October 2004 and is a large state-owned enterprise directly managed by the State-owned Assets Supervision and Administration Commission [1] - The company has evolved into a comprehensive agricultural production and service enterprise, covering six core industries: seed industry, fishery, animal husbandry, agricultural planting, agricultural machinery, and service trade [2] - As of the end of 2024, the group has nearly 300 member enterprises and three listed companies, with projects in over 30 countries [2] Group 2: Financial Performance - For the first half of 2025, China Agri-Development Group's listed companies reported the following: - China Agri-Seed Industry Group achieved revenue of 2.916 billion yuan, a year-on-year increase of 47.86%, and a net profit of 63.04 million yuan, up 14.13% [2][3] - China Water Group's revenue was 1.747 billion yuan, a decrease of 10.66%, while net profit rose to 86.31 million yuan, an increase of 22.12% [3] - China Animal Husbandry's revenue reached 2.793 billion yuan, a growth of 12.63%, with net profit at 81.76 million yuan, up 30.19% [3][4] Group 3: Strategic Initiatives - China Agri-Seed Industry focused on innovation and research, with eight new crop varieties approved during the first half of the year and 53 research projects initiated [3] - China Water Group adopted a high-quality development approach, overcoming challenges and enhancing production safety while managing risks effectively [3] - China Animal Husbandry implemented various measures to improve operational performance amidst a competitive market, maintaining market share and resilience [4]

Market Overview - The animal health sector increased by 1.25% on September 5, with Yongshun Biological leading the gains [1] - The Shanghai Composite Index closed at 3812.51, up 1.24%, while the Shenzhen Component Index closed at 12590.56, up 3.89% [1] Stock Performance - Yongshun Biological (839729) closed at 10.82, up 4.14% with a trading volume of 44,500 shares and a turnover of 47.80 million yuan [1] - Shilian Biological (688098) closed at 11.76, up 3.16% with a trading volume of 114,100 shares and a turnover of 132 million yuan [1] - Other notable performers include: - Houfeng Holdings (002141): closed at 3.96, up 2.33% [1] - KQ Biological (688526): closed at 18.00, up 2.16% [1] - Dayu Biological (871970): closed at 10.25, up 2.09% [1] Capital Flow - The animal health sector experienced a net outflow of 37.19 million yuan from institutional investors, while retail investors saw a net inflow of 13.24 million yuan [2] - Notable capital flows include: - Shilian Biological: net inflow of 500.11 thousand yuan from institutional investors [3] - Houfeng Holdings: net inflow of 91.15 thousand yuan from retail investors [3] - KQ Biological: net outflow of 297.54 thousand yuan from institutional investors [3]

股票代码：600195 股票简称：中牧股份 编号：临 2025-026 中牧实业股份有限公司关于 行使优先配售权参与认购厦门金达威集团股份有限公司向不特 定对象发行可转换公司债券的结果公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏， 并对其内容的真实性、准确性和完整性承担法律责任。 2025 年 8 月 18 日，中牧实业股份有限公司（以下简称"公司"）召开第九届董事会 2025 年第十次临时会议、第九届监事会 2025 年第一次临时会议审议通过了《关于公司行使优先配 售权参与认购厦门金达威集团股份有限公司向不特定对象发行可转换公司债券的议案》。具体 内容详见 2025 年 8 月 20 日刊登在《上海证券报》以及上海证券交易所网站（www.sse.com.cn） 的《中牧实业股份有限公司关于行使优先配售权参与认购厦门金达威集团股份有限公司向不特 定对象发行可转换公司债券的公告》（编号：临 2025-022）。 2025 年 8 月 20 日，公司通过深圳证券交易所交易系统认购厦门金达威集团股份有限公司 （以下简称"金达威"）可转换公司债券 2,414,012 张，单价为 ...

Market Overview - The animal health sector experienced a decline of 0.2% on September 4, with Shunlian Biological leading the drop [1] - The Shanghai Composite Index closed at 3765.88, down 1.25%, while the Shenzhen Component Index closed at 12118.7, down 2.83% [1] Stock Performance - Notable gainers in the animal health sector included: - Qudongli (code: 838275) with a closing price of 11.96, up 6.50% [1] - Dayu Biological (code: 871970) with a closing price of 10.04, up 3.40% [1] - Yongshun Biological (code: 839729) with a closing price of 10.39, up 2.26% [1] - Conversely, Shunlian Biological (code: 688098) saw a decline of 2.98%, closing at 11.40 [2] Trading Volume and Capital Flow - The total trading volume for the animal health sector showed a net outflow of 85.41 million yuan from institutional investors, while retail investors saw a net inflow of 74.17 million yuan [2] - The capital flow for individual stocks indicated significant movements, with Shunlian Biological experiencing a net outflow of 10.12 million yuan from institutional investors [3] Individual Stock Analysis - Shunlian Biological had a total trading volume of 131,200 shares, with a net inflow of 7.73 million yuan from retail investors [3] - Other stocks like Huisheng Biological (code: 300871) and ST Green Kang (code: 002868) also showed varied capital flows, with Huisheng experiencing a net outflow of 12.50 million yuan from speculative funds [3]

Core Viewpoint - The company Zhongmu Co., Ltd. (600195.SH) has stated that it currently does not export any vaccine products to EU countries [1] Company Summary - Zhongmu Co., Ltd. has confirmed through an interactive platform that there are no vaccine exports to the European Union at this time [1]